Natarajan Sethuraman Ph. D
President of Research and Development
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Entrada Therapeutics, Inc. (TRDA) | President of Research and Development | $520,000 | $2,254,315 |
| 2024 | Entrada Therapeutics, Inc. (TRDA) | President of Research and Development | $493,232 | $1,962,700 |
| 2023 | Entrada Therapeutics, Inc. (TRDA) | President of Research and Development | $456,501 | $1,485,455 |
| 2022 | Entrada Therapeutics, Inc. (TRDA) | Chief Scientific Officer | $440,000 | $1,618,915 |
| 2021 | Entrada Therapeutics, Inc. (TRDA) | Chief Scientific Officer | $382,939 | $4,306,614 |
| 2020 | Entrada Therapeutics, Inc. (TRDA) | Chief Scientific Officer | $359,625 | $579,765 |
Earnings-call appearances
No earnings-call appearances recorded yet.